Abstract
The process for catalytic radioiodine labelling of o-iodohippuric acid at a 40 GBq level of Nal31I is described. The in vitro stability of this radiopharmaceutical was investigated and different variants are shown for improving radiochemical purity. The described labelling procedure is used in the routine-production process.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Isotopenpraxis Isotopes in Environmental and Health Studies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
